ArticleFrontiers in medicine2024

The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials.

Mustafa Arici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.